Prognostic Analysis for Patients With Parathyroid Carcinoma: A Population-Based Study

被引:14
作者
Qian, Bei [1 ]
Qian, Ying [2 ]
Hu, Longqing [1 ]
Zhang, Shoupeng [1 ]
Mei, Li [1 ]
Qu, Xincai [1 ]
机构
[1] Huazhong Univ Sci & Technol, Union Hosp, Dept Thyroid & Breast Surg, Tongji Med Coll, Wuhan, Peoples R China
[2] Yangtze Univ, Jingzhou Hosp, Dept Pharm, Jingzhou, Peoples R China
关键词
parathyroid carcinoma; prognostic factor; cancer-specific survival (CSS); nomogram; validation; MANAGEMENT; SURVIVAL; OUTCOMES; CANCER;
D O I
10.3389/fnins.2022.784599
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
BackgroundParathyroid carcinoma (PC) is a rare but often lethal malignancy for which staging system, prognostic indicators, and treatment guidelines are still not established. We aimed to explore the prognostic parameters and construct a nomogram for cancer-specific survival (CSS) of PC. MethodsA retrospective analysis of 604 PC patients in the SEER database from 2001 through 2018 was performed. All the cases were randomly assigned to the training cohort (n = 424) or the validation cohort (n = 180) at a ratio of 7:3. The Kaplan-Meier method and Cox regression model were applied to estimate the CSS and risk factors, and a nomogram was constructed. The predictive accuracy and discriminative ability of the nomogram in CSS were assessed by concordance index (C-index), the area under the curve (AUC) of receiver operating characteristics (ROC), and the calibration curve. ResultsAge at diagnosis > 70 years [hazard ratio (HR): 3.55, 95% CI: 1.07-11.78, p = 0.039] and tumor size > 35 mm (HR 4.22, 95% CI: 1.67-10.68, p = 0.002) were associated with worse CSS. Compared with distant metastasis, localized (HR 0.17, 95% CI: 0.06-0.47, p = 0.001) and regional lesions (HR 0.22, 95% CI: 0.07-0.66, p = 0.007) showed an improved CSS rate. Parathyroidectomy was the recommended treatment (p = 0.02). The C-index of the nomogram was 0.826, and the AUC for 5-, 10-, and 15-year CSS was 83.7%, 79.7%, and 80.7%, respectively. The calibration curve presented good agreement between prediction by nomogram and actual observation. ConclusionAge at diagnosis > 70 years, tumor size > 35 mm, and distant metastasis were independent risk factors for PC-specific mortality. Parathyroidectomy was currently the most recommended treatment for PC. This nomogram provided individualized assessment and reliable prognostic prediction for patients with PC.
引用
收藏
页数:12
相关论文
共 31 条
  • [11] Parathyroid carcinoma.
    Kebebew E.
    [J]. Current Treatment Options in Oncology, 2001, 2 (4) : 347 - 354
  • [12] Trends in the incidence and treatment of parathyroid cancer in the United States
    Lee, Peter K.
    Jarosek, Stephanie L.
    Virnig, Beth A.
    Evasovich, Maria
    Tuttle, Todd M.
    [J]. CANCER, 2007, 109 (09) : 1736 - 1741
  • [13] Clinical Presentation, Treatment, and Outcome of Parathyroid Carcinoma Results of the NEKAR Retrospective International Multicenter Study
    Lenschow, Christina
    Schraegle, Sina
    Kircher, Stefan
    Lorenz, Kerstin
    Machens, Andreas
    Dralle, Henning
    Riss, Philipp
    Scheuba, Christian
    Pfestroff, Andreas
    Spitzweg, Christine
    Zielke, Andreas
    Niessen, Anna
    Dotzenrath, Cornelia
    Riemann, Burkhard
    Quinkler, Marcus
    Vorlaender, Christian
    Zahn, Alexandra
    Raue, Friedhelm
    Chiapponi, Costanza
    Iwen, Karl Alexander
    Steinmueller, Thomas
    Kroiss, Matthias
    Schlegel, Nicolas
    [J]. ANNALS OF SURGERY, 2022, 275 (02) : E479 - E487
  • [14] The Use and Benefit of Adjuvant Radiotherapy in Parathyroid Carcinoma: A National Cancer Database Analysis
    Limberg, Jessica
    Stefanova, Dessislava
    Ullmann, Timothy M.
    Thiesmeyer, Jessica W.
    Bains, Sarina
    Beninato, Toni
    Zarnegar, Rasa
    Fahey, Thomas J., III
    Finnerty, Brendan M.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (01) : 502 - 511
  • [15] Tumor Size and Presence of Metastatic Disease at Diagnosis are Associated with Disease-Specific Survival in Parathyroid Carcinoma
    Lo, Winifred M.
    Good, Meghan L.
    Nilubol, Naris
    Perrier, Nancy D.
    Patel, Dhaval T.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2018, 25 (09) : 2535 - 2540
  • [16] Parathyroid carcinoma
    Rawat, N
    Khetan, N
    Williams, DW
    Baxter, JN
    [J]. BRITISH JOURNAL OF SURGERY, 2005, 92 (11) : 1345 - 1353
  • [17] Parathyroid cancer: An update
    Rodrigo, Juan P.
    Hernandez-Prera, Juan C.
    Randolph, Gregory W.
    Zafereo, Mark E.
    Hartl, Dana M.
    Silver, Carl E.
    Suarez, Carlos
    Owen, Randall P.
    Bradford, Carol R.
    Makitie, Antti A.
    Shaha, Ashok R.
    Bishop, Justin A.
    Rinaldo, Alessandra
    Ferlito, Alfio
    [J]. CANCER TREATMENT REVIEWS, 2020, 86
  • [18] Parathyroid carcinoma in more than 1,000 patients: A population-level analysis
    Sadler, Claire
    Gow, Kenneth W.
    Beierle, Elizabeth A.
    Doski, John J.
    Langer, Monica
    Nuchtern, Jed G.
    Vasudevan, Sanjeev A.
    Goldfarb, Melanie
    [J]. SURGERY, 2014, 156 (06) : 1622 - 1630
  • [19] Parathyroid carcinoma
    Salcuni, Antonio Stefano
    Cetani, Filomena
    Guarnieri, Vito
    Nicastro, Vincenzo
    Romagnoli, Elisabetta
    de Martino, Danilo
    Scillitani, Alfredo
    Cole, David E. C.
    [J]. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2018, 32 (06) : 877 - 889
  • [20] SCHANTZ A, 1973, CANCER-AM CANCER SOC, V31, P600, DOI 10.1002/1097-0142(197303)31:3<600::AID-CNCR2820310316>3.0.CO